All Supplements
    Supplement

    Pine Bark Extract (Pycnogenol)New

    Supplement
    Polyphenols
    4/10 Evidence

    A standardized extract of French maritime pine bark rich in procyanidins, studied for blood pressure, circulation, joint comfort and skin. Evidence is mixed and much of it comes from trials linked to the manufacturer of the branded extract.

    Mechanism of Action

    Procyanidins and phenolic acids scavenge free radicals, inhibit NF-kB and COX-2 inflammatory signalling and may increase endothelial nitric oxide synthase activity, supporting vasodilation. Effects appear specific to standardized extracts (about 65-75% procyanidins).

    Dosing Protocol

    Recommended

    100mg per day of standardized extract (65-75% procyanidins)

    Standard starting dose based on research

    Therapeutic Range

    50

    Minimum

    to

    200

    Maximum

    mg per day of standardized extract (65-75% procyanidins)

    Daily with food, once or divided twice daily

    Cycling Protocol

    No established cycling. Reassess benefit (blood pressure, joint symptoms) after 8-12 weeks and stop if no benefit

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • A 2020 Phytotherapy Research meta-analysis of 12 trials (922 participants) reported small blood-pressure reductions (SBP -3.2 mmHg, 95% CI -5.5 to -0.9; DBP -1.9 mmHg)
    • A 2020 Angiology review restricted to double-blind placebo-controlled RCTs found no significant systolic benefit (WMD -0.03 mmHg), so the blood-pressure signal is not settled
    • Small trials report reduced pain and stiffness in knee osteoarthritis at 100 mg/day (no systematic review located)

    Secondary Benefits

    Possible improvements in skin hydration and elasticity in small trials
    Possible improvements in endothelial function and chronic venous insufficiency symptoms
    Possible modest effects on oxidative-stress markers

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • •Bleeding disorders or planned surgery within 2 weeks
    • •Autoimmune disease or transplant on immunosuppressants
    • •Pregnancy and breastfeeding (insufficient data)
    • •Known pine or conifer allergy

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel) - theoretical additive bleeding risk
    Antihypertensives and diabetes medications - additive effects; monitor
    Immunosuppressants - possible immune stimulation; avoid without clinician guidance
    Stop about 2 weeks before surgery

    Potential Side Effects

    Some users may experience:

    Mild GI upset or nausea
    Headache or dizziness
    Rarely, allergic reaction
    Possible increased bruising with anticoagulants

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Standardized to 65-75% procyanidins
    • Branded, trial-tested extract (e.g. Pycnogenol) rather than generic bark powder
    • Third-party tested for heavy metals and solvent residues
    • Dose stated in mg of extract, not mg of bark

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    4/10

    Emerging/Anecdotal

    Limited clinical data, primarily mechanistic studies or user reports

    Classification:
    Emerging (scored 4). Two 2020 meta-analyses reach opposite conclusions on blood pressure: one finds a small reduction across 12 trials, the other finds none when only double-blind placebo-controlled RCTs are included. I found no meta-analysis for osteoarthritis, only secondary summaries of small trials. Trials are small, short and frequently manufacturer-linked, and no hard-outcome trials exist. Search was summary-level and should be confirmed against full papers. Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation